You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PRAME

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ambiguous Melanocytic Proliferation

Not yet recruiting
  • Melanoma
  • Immunomarkers
  • Strasbourg, France
    Les Hôpitaux Universitaires de Strasbourg
Oct 11, 2021

Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

Not yet recruiting
  • Refractory Cancer
  • +3 more
  • IMA402 (Phase Ia)
  • +2 more
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +12 more
Jul 14, 2023

Select Advanced Solid Tumors Trial in United Kingdom, United States (IMC-F106C, anti-PD(L)1)

Recruiting
  • Select Advanced Solid Tumors
  • Los Angeles, California
  • +12 more
Mar 10, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Uveal Melanoma Trial in Denver, Portland, Nashville (BPX-701, Rimiducid)

Unknown status
  • Acute Myeloid Leukemia
  • +2 more
  • Denver, Colorado
  • +2 more
Apr 23, 2020

Acute Myeloid Leukemia Trial in Oslo (WT1/PRAME vaccination)

Completed
  • Acute Myeloid Leukemia
  • WT1/PRAME vaccination
  • Oslo, Norway
    Oslo University Hospital, Rikshospitalet
Jul 6, 2020

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Infusion of NEXI-001 T Cells
  • Duarte, California
  • +4 more
Feb 16, 2021

Safety, Tolerability, Feasibility Trial in Germany (MDG1011, Investigator Choice therapy)

Recruiting
  • Safety
  • +3 more
  • Dresden, Germany
  • +8 more
Jan 8, 2020

Spanish Registry of Patients With IgM Monoclonal Gammopathies

Recruiting
  • Waldenstrom Macroglobulinemia
    • Mieres, Asturias, Spain
    • +24 more
    Jul 5, 2022

    Skin Lesion, Nevus Trial (DermTech PLA noninvasive adhesive biopsy)

    Not yet recruiting
    • Skin Lesion
    • Nevus
    • DermTech PLA noninvasive adhesive biopsy
    • (no location specified)
    Jun 13, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Melanoma Trial in Worldwide (Immunotherapeutic GSK2302025A, different formulations)

    Completed
    Has Results
    • Melanoma
    • Immunotherapeutic GSK2302025A, different formulations
    • Brno, Czechia
    • +36 more
    Oct 23, 2020

    Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

    Recruiting
    • Breast Cancer
    • Chidamide Plus Toripalimab Plus Paclitaxel
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 19, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (MultiTAA-specific T cells)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • MultiTAA-specific T cells
    • Houston, Texas
    • +1 more
    May 31, 2022

    Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

    Completed
    Has Results
    • Cutaneous Melanoma
    • +11 more
    • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    • +2 more
    • Chicago, Illinois
    • +6 more
    Nov 10, 2021

    Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

    Not yet recruiting
    • Advanced Melanoma
    • IMC-F106C
    • +2 more
    • La Jolla, California
    • +61 more
    Oct 31, 2023

    Lung Cancer, Non-Small Cell Trial in Worldwide (Recombinant PRAME protein combined with the AS15 Adjuvant System GSK2302032A,

    Completed
    Has Results
    • Lung Cancer, Non-Small Cell
    • Recombinant PRAME protein combined with the AS15 Adjuvant System GSK2302032A
    • Placebo
    • Newark, Delaware
    • +38 more
    Aug 23, 2019

    Relapsed Neuroblastoma Trial in Minsk (DNA vaccine, Salmonella oral vaccine, Lenalidomide)

    Recruiting
    • Relapsed Neuroblastoma
    • DNA vaccine
    • +2 more
    • Minsk, Minsk Region, Belarus
      Belarussian Research Center for Pediatric Oncology, Hematology a
    Mar 1, 2022

    Ovarian Cancer Trial in Groningen (DCP-001)

    Recruiting
    • Ovarian Cancer
    • DCP-001
    • Groningen, Netherlands
      UMCG
    Nov 25, 2021

    AML/MDS Trial in United States (Mana 312)

    Active, not recruiting
    • AML/MDS
    • Mana 312
    • Denver, Colorado
    • +7 more
    Jun 13, 2022

    Leukemia, Lymphoblastic (Acute) Trial in Houston (MultiTAA-specific T cells)

    Active, not recruiting
    • Leukemia, Lymphoblastic (Acute)
    • MultiTAA-specific T cells
    • Houston, Texas
    • +1 more
    Aug 6, 2021

    Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)

    Active, not recruiting
    • Melanoma, Uveal Metastatic
    • Vaccination with IKKb matured Dendritic Cells
    • Erlangen, Bavaria, Germany
      University Hospital Erlangen Dept. of Dermatology
    Mar 16, 2022

    Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS Trial in Washington, Baltimore (Tumor associated

    Recruiting
    • Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
    • Tumor associated antigen lymphocytes (TAA-T)
    • Washington, District of Columbia
    • +1 more
    Jul 15, 2021

    Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Herlev (NPMW-peptide vaccine, Azacitidine)

    Completed
    • Myelodysplastic Syndrome
    • Acute Myeloid Leukemia
    • Herlev, Denmark
      Dept of Hematology, Herlev Hospital
    Nov 23, 2020

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021